The FDA Approved Nuedexta ™ (dextromethorphan hydrobromide and quinidine sulfate). It is the first drug developed specifically to treat uncontrollable laughing or crying, also called pseudobulbar affect, or PBA.
Pseudobulbar Affect (PBA), which affects those who suffer from MS (as well as other neurological diseases and conditions). It is characterized by uncontrolled, inappropriate, and/or exaggerated episodes of crying, laughing, or other emotional display, occurring with only minimal or no stimulation to such a response.
Please visit our website or on Facebook